Kayne Anderson Rudnick Investment Management LLC Becton Dickinson & CO Transaction History

Kayne Anderson Rudnick Investment Management LLC

  • $43.7 Billion
  • Q3 2024

A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 91 shares of BDX stock, worth $20,384. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91
Previous 91 -0.0%
Holding current value
$20,384
Previous $21,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$232.24 - $267.23 $1,161 - $1,336
5 Added 5.81%
91 $22,000
Q3 2023

Nov 13, 2023
SELL
$254.9 - $283.59 $5.53 Million - $6.15 Million
-21,695 Reduced 99.61%
86 $22,000
Q2 2023

Aug 11, 2023
SELL
$238.39 - $265.32 $6.96 Million - $7.75 Million
-29,205 Reduced 57.28%
21,781 $5.75 Million
Q1 2023

May 16, 2023
SELL
$229.71 - $259.35 $10.9 Million - $12.3 Million
-47,525 Reduced 48.24%
50,986 $12.6 Million
Q4 2022

Feb 13, 2023
BUY
$218.29 - $256.91 $929,478 - $1.09 Million
4,258 Added 4.52%
98,511 $25.1 Million
Q3 2022

Nov 16, 2022
BUY
$51.03 - $264.23 $4.81 Million - $24.9 Million
94,253 New
94,253 $21 Million
Q3 2022

Nov 14, 2022
SELL
$51.03 - $264.23 $4.07 Million - $21.1 Million
-79,752 Closed
0 $21 Million
Q2 2022

Aug 12, 2022
BUY
$234.74 - $275.42 $1.27 Million - $1.49 Million
5,407 Added 7.27%
79,752 $19.7 Million
Q1 2022

May 16, 2022
BUY
$243.64 - $270.48 $819,848 - $910,165
3,365 Added 4.74%
74,345 $19.8 Million
Q4 2021

Feb 14, 2022
SELL
$230.08 - $250.94 $457,399 - $498,868
-1,988 Reduced 2.72%
70,980 $17.9 Million
Q3 2021

Nov 12, 2021
BUY
$232.72 - $256.47 $133,115 - $146,700
572 Added 0.79%
72,968 $17.9 Million
Q2 2021

Aug 13, 2021
BUY
$232.65 - $254.58 $278,249 - $304,477
1,196 Added 1.68%
72,396 $17.6 Million
Q1 2021

May 17, 2021
BUY
$232.09 - $256.88 $1.1 Million - $1.22 Million
4,755 Added 7.16%
71,200 $17.3 Million
Q4 2020

Feb 12, 2021
SELL
$221.92 - $245.94 $105,412 - $116,821
-475 Reduced 0.71%
66,445 $16.6 Million
Q3 2020

Nov 16, 2020
BUY
$215.77 - $276.76 $684,206 - $877,605
3,171 Added 4.97%
66,920 $15.6 Million
Q2 2020

Aug 14, 2020
BUY
$219.9 - $263.41 $595,049 - $712,787
2,706 Added 4.43%
63,749 $15.3 Million
Q1 2020

May 15, 2020
BUY
$195.69 - $279.01 $530,906 - $756,954
2,713 Added 4.65%
61,043 $14 Million
Q4 2019

Feb 13, 2020
BUY
$236.45 - $266.82 $528,465 - $596,342
2,235 Added 3.98%
58,330 $15.9 Million
Q3 2019

Nov 14, 2019
BUY
$230.58 - $256.08 $1.24 Million - $1.37 Million
5,357 Added 10.56%
56,095 $14.2 Million
Q2 2019

Aug 14, 2019
BUY
$217.4 - $246.08 $490,671 - $555,402
2,257 Added 4.66%
50,738 $12.8 Million
Q1 2019

Jun 12, 2019
SELL
$206.05 - $248.17 $53,573 - $64,524
-260 Reduced 0.53%
48,481 $12.1 Million
Q1 2019

May 10, 2019
SELL
$206.05 - $248.17 $2.11 Million - $2.54 Million
-10,235 Reduced 17.35%
48,741 $12.2 Million
Q4 2018

Feb 06, 2019
SELL
$204.73 - $257.93 $255,298 - $321,638
-1,247 Reduced 2.07%
58,976 $13.3 Million
Q3 2018

Nov 13, 2018
SELL
$233.07 - $256.0 $478,259 - $525,312
-2,052 Reduced 3.3%
60,223 $15.7 Million
Q2 2018

Aug 13, 2018
SELL
$208.1 - $233.85 $351,897 - $395,440
-1,691 Reduced 2.64%
62,275 $14.9 Million
Q1 2018

May 09, 2018
SELL
$205.46 - $240.27 $689,934 - $806,826
-3,358 Reduced 4.99%
63,966 $13.9 Million
Q4 2017

Feb 12, 2018
SELL
$189.0 - $222.64 $140,427 - $165,421
-743 Reduced 1.09%
67,324 $14.4 Million
Q3 2017

Nov 07, 2017
BUY
$186.89 - $198.9 $12.7 Million - $13.5 Million
68,067
68,067 $13.3 Million

Others Institutions Holding BDX

# of Institutions
1,737
Shares Held
250M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Kayne Anderson Rudnick Investment Management LLC Portfolio

Follow Kayne Anderson Rudnick Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email